MYGN logo

Myriad Genetics (MYGN) Operating Margin

Annual Operating Margin

-19.20%
-0.97%-5.32%

December 31, 2023

Summary

Performance

1-Year Change

-5.32%

3-Year Change

+34.45%

5-Year Change

-2257.3%

15-Year Change

-423.78%

MYGN Operating Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61.35%
MYGN annual operating profit margin is higher than 61.35% of companies in Healthcare sector

High & Low

All-time High

39.24%
MYGN annual operating profit margin is currently -148.93% below its historical high of 39.24%

3-Year Low

-19.20%
MYGN annual operating profit margin is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
MYGN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 27, 2025
MYGN next annual earnings announcement is scheduled for Feb 27, 2025

OtherMYGNprofitabilitymetrics:

Annual Operating Profit

-$144.60 M
MYGN annual operating income is -$144.60 million

Annual Revenue

$753.20 M
MYGN annual revenue is $753.20 million

Annual Gross Margin

68.64%
MYGN annual gross profit margin is 68.64%

Annual Net Margin

-34.96%
MYGN annual net profit margin is -34.96%

Quarterly Operating Margin

-8.35%
+3.42%+29.06%

September 30, 2024

Summary

Performance

3-Month Change

+29.06%

1-Year Change

+45.99%

3-Year Change

+45.99%

5-Year Change

+45.99%

MYGN Quarterly Operating Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61.54%
MYGN quarterly operating profit margin is higher than 61.54% of companies in Healthcare sector

High & Low

All-time High

160.01%
MYGN quarterly operating profit margin is currently -105.22% below its historical high of 160.01%

3-Year Low

-28.81%

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MYGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 27, 2025
MYGN next earnings announcement is scheduled for Feb 27, 2025

OtherMYGNprofitabilitymetrics:

Quarterly Operating Profit

-$17.80 M
MYGN quarterly operating income is -$17.80 million

Quarterly Revenue

$213.30 M
MYGN quarterly revenue is $213.30 million

Quarterly Gross Margin

70.23%
MYGN quarterly gross profit margin is 70.23%

Quarterly Net Margin

-10.36%
MYGN quarterly net profit margin is -10.36%

Operating Margin Formula

Operating Profit Margin =  Operating Profit
Revenue ✕ 100%

Annual Operating Margin

-19.20%
MYGN annual operating profit margin is -19.20%

Annual Operating Profit

-$144.60 M
MYGN annual operating income is -$144.60 million

Annual Revenue

$753.20 M
MYGN annual revenue is $753.20 million

MYGN Operating Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-5.3%+46.0%
3 y3 years+34.5%+46.0%
5 y5 years-2257.3%+46.0%

MYGN Operating Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-5.3%at low-171.1%+71.0%
5 y5-year-2257.3%+34.5%-171.1%+88.1%
alltimeall time-148.9%+85.8%-105.2%+95.0%

Myriad Genetics Operating Margin History

DateAnnualQuarterly
Sep 2024
-
-8.35%(-29.1%)
Jun 2024
-
-11.77%(-14.7%)
Mar 2024
-
-13.80%(-10.7%)
Dec 2023
-19.20%(+5.3%)
-15.46%(+15.0%)
Sep 2023
-
-13.44%(-31.9%)
Jun 2023
-
-19.73%(-31.5%)
Mar 2023
-
-28.81%(+11.4%)
Dec 2022
-18.23%(-0.7%)
-25.87%(-10.1%)
Sep 2022
-
-28.77%(+189.7%)
Jun 2022
-
-9.93%(+9.8%)
Mar 2022
-
-9.04%(-176.9%)
Dec 2021
-18.35%(-37.4%)
11.75%(-124.6%)
Sep 2021
-
-47.76%(+376.2%)
Jun 2021
-
-10.03%(-62.1%)
Mar 2021
-
-26.46%(-5.6%)
Dec 2020
-29.29%(+41.7%)
-
Sep 2020
-
-28.03%(-60.1%)
Jun 2020
-20.67%(-2422.5%)
-70.28%(+197.8%)
Mar 2020
-
-23.60%(+417.5%)
Dec 2019
-
-4.56%(-57.9%)
Sep 2019
-
-10.84%(+233.5%)
Jun 2019
0.89%(-89.1%)
-3.25%(-219.5%)
Mar 2019
-
2.72%(-16.8%)
Dec 2018
-
3.27%(+313.9%)
Sep 2018
-
0.79%(-91.3%)
Jun 2018
8.16%(+37.6%)
9.13%(+32.7%)
Mar 2018
-
6.88%(-33.0%)
Dec 2017
-
10.27%(+70.0%)
Sep 2017
-
6.04%(-11.7%)
Jun 2017
5.93%(-71.4%)
6.84%(+4.4%)
Mar 2017
-
6.55%(-2.5%)
Dec 2016
-
6.72%(+92.6%)
Sep 2016
-
3.49%(-72.8%)
Jun 2016
20.72%(+11.6%)
12.83%(-42.6%)
Mar 2016
-
22.36%(-4.4%)
Dec 2015
-
23.38%(-0.9%)
Sep 2015
-
23.60%(+23.8%)
Jun 2015
18.56%(-47.4%)
19.06%(-3.9%)
Mar 2015
-
19.83%(+0.7%)
Dec 2014
-
19.69%(+28.4%)
Sep 2014
-
15.34%(-45.6%)
Jun 2014
35.26%(-5.2%)
28.19%(-6.7%)
Mar 2014
-
30.22%(-25.7%)
Dec 2013
-
40.67%(-0.7%)
Sep 2013
-
40.95%(+8.2%)
Jun 2013
37.18%(+2.3%)
37.85%(+2.3%)
Mar 2013
-
37.01%(-0.7%)
Dec 2012
-
37.27%(+2.4%)
Sep 2012
-
36.41%(+2.4%)
Jun 2012
36.35%(-7.4%)
35.56%(+0.1%)
Mar 2012
-
35.52%(-4.1%)
Dec 2011
-
37.02%(-1.4%)
Sep 2011
-
37.55%(-3.4%)
Jun 2011
39.24%(+5.3%)
38.89%(-4.8%)
Mar 2011
-
40.85%(+6.3%)
Dec 2010
-
38.42%(-0.9%)
Sep 2010
-
38.75%(-3.2%)
Jun 2010
37.25%
40.05%(+9.5%)
DateAnnualQuarterly
Mar 2010
-
36.58%(-1.7%)
Dec 2009
-
37.21%(+6.6%)
Sep 2009
-
34.91%(-12.9%)
Jun 2009
38.73%(+40.1%)
40.07%(-1.7%)
Mar 2009
-
40.75%(+2.7%)
Dec 2008
-
39.69%(+119.6%)
Sep 2008
-
18.07%(-88.7%)
Jun 2008
27.64%(-191.0%)
160.01%(-1364.9%)
Mar 2008
-
-12.65%(-17.9%)
Dec 2007
-
-15.40%(-35.8%)
Sep 2007
-
-24.00%(-11.0%)
Jun 2007
-30.38%(-23.8%)
-26.97%(+21.5%)
Mar 2007
-
-22.19%(-172.5%)
Dec 2006
-
30.62%(-168.5%)
Sep 2006
-
-44.72%(+2.4%)
Jun 2006
-39.89%(-19.3%)
-43.66%(+8.9%)
Mar 2006
-
-40.10%(+14.1%)
Dec 2005
-
-35.13%(-12.2%)
Sep 2005
-
-40.03%(+19.5%)
Jun 2005
-49.44%(-34.3%)
-33.50%(-37.6%)
Mar 2005
-
-53.65%(-1.3%)
Dec 2004
-
-54.36%(-14.4%)
Sep 2004
-
-63.54%(-12.3%)
Jun 2004
-75.26%(+77.0%)
-72.47%(-10.7%)
Mar 2004
-
-81.16%(+10.6%)
Dec 2003
-
-73.37%(-1.3%)
Sep 2003
-
-74.37%(+52.2%)
Jun 2003
-42.51%(+22.6%)
-48.87%(+28.7%)
Mar 2003
-
-37.98%(-13.7%)
Dec 2002
-
-44.00%(+12.4%)
Sep 2002
-
-39.15%(-26.0%)
Jun 2002
-34.66%(+19.1%)
-52.92%(+55.6%)
Mar 2002
-
-34.02%(+21.2%)
Dec 2001
-
-28.07%(+24.8%)
Sep 2001
-
-22.49%(-29.5%)
Jun 2001
-29.09%(-14.3%)
-31.92%(+13.4%)
Mar 2001
-
-28.16%(+5.0%)
Dec 2000
-
-26.81%(-9.9%)
Sep 2000
-
-29.76%(-22.3%)
Jun 2000
-33.95%(-30.7%)
-38.28%(+23.0%)
Mar 2000
-
-31.12%(+12.3%)
Dec 1999
-
-27.71%(-29.2%)
Sep 1999
-
-39.13%(-8.7%)
Jun 1999
-49.01%(-12.5%)
-42.85%(+14.7%)
Mar 1999
-
-37.35%(-40.9%)
Dec 1998
-
-63.16%(+4.0%)
Sep 1998
-
-60.71%(+3.8%)
Jun 1998
-56.03%(-31.9%)
-58.46%(-4.8%)
Mar 1998
-
-61.40%(+1.0%)
Dec 1997
-
-60.78%(+32.8%)
Sep 1997
-
-45.76%(+586.1%)
Jun 1997
-82.24%(-39.0%)
-6.67%(-95.5%)
Mar 1997
-
-148.15%(-3.5%)
Dec 1996
-
-153.57%(-8.7%)
Sep 1996
-
-168.18%(+16.0%)
Jun 1996
-134.85%
-145.00%(+2.0%)
Mar 1996
-
-142.11%(+27.2%)
Dec 1995
-
-111.76%

FAQ

  • What is Myriad Genetics annual operating profit margin?
  • What is the all time high annual operating margin for Myriad Genetics?
  • What is Myriad Genetics annual operating margin year-on-year change?
  • What is Myriad Genetics quarterly operating profit margin?
  • What is the all time high quarterly operating margin for Myriad Genetics?
  • What is Myriad Genetics quarterly operating margin year-on-year change?

What is Myriad Genetics annual operating profit margin?

The current annual operating margin of MYGN is -19.20%

What is the all time high annual operating margin for Myriad Genetics?

Myriad Genetics all-time high annual operating profit margin is 39.24%

What is Myriad Genetics annual operating margin year-on-year change?

Over the past year, MYGN annual operating profit margin has changed by -0.97% (-5.32%)

What is Myriad Genetics quarterly operating profit margin?

The current quarterly operating margin of MYGN is -8.35%

What is the all time high quarterly operating margin for Myriad Genetics?

Myriad Genetics all-time high quarterly operating profit margin is 160.01%

What is Myriad Genetics quarterly operating margin year-on-year change?

Over the past year, MYGN quarterly operating profit margin has changed by +7.11% (+45.99%)